Iksuda Therapeutics at World ADC London 2027

Mar 8–11, 2027 London, UK ~700 attendees Website

Iksuda Therapeutics takes part in 4 sessions at World ADC London 2027 in London. Its sessions cover how new ADC designs translate into better clinical results, and where next-generation and dual-payload ADCs fit as standard-of-care therapies.

OrganizationWorld ADC London 2027 Attendance
Iksuda Therapeutics
Newcastle upon Tyne, UK
iksuda.com
Biotech
UK ADC developer with clinical programs and new payload classes, including a protein-alkylating payload.
Panel
Tue Mar 9
9:30am
CEO & ADC Pharma Leaders Think Tank: Solidifying Next Generation ADCs as Standard of Care Therapies
Plenary · with Araris Biotech, Oxford BioTherapeutics, Boehringer Ingelheim
Clinical development
Panel
Tue Mar 9
5:00pm
Trailblazing Next Generation of ADC’s from XDC’s to Dual Payload Innovation to Develop Safer & More Efficacious ADC Drugs from Concept to Clinic Validation
Plenary · with Queen's University Belfast, University of Michigan, Callio Therapeutics
ADC discoveryClinical development
Talk
Novel ADC Designs Drive Improved Clinical Outcomes
Clinical Lessons
ADC discovery
Workshop
Thu Mar 11
1:00pm
Leveraging Clinical Outcomes & Performance to Inform the Development of Novel ADC Design
Post-conference workshop for Clinical Lessons · with Oxford BioTherapeutics
ADC discovery

Explore the full World ADC London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full World ADC London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Iksuda Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World ADC or its organizers. Submit a correction